Patent · US Active

Imidazole derivatives as inhibitors of TAFIa

US8044208B2 · kind B2 · utility

2Cited by

0References

6Claims

0Family size

Assignee

Sanofi-Aventis · FR

Inventors

Christopher Kallus · Frankfurt am Main, DE
Holger Heitsch · Hofheim, DE
Volkmar Wehner · Bischofsheim a.d.Rhön, DE

Key dates

Filing date	Apr 14, 2008
Grant date	Oct 25, 2011
Priority date	—
Expiry date	Feb 11, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to a compound of formula I:or any stereoisomeric form of the compound of the formula I or a mixture of these forms in any ratio or a physiologically acceptable salt of the compound of the formula I which inhibit the enzyme TAFIa (activated thrombin-activatable fibrinolysis inhibitor), and to a process for their preparation and to their use to treat described diseases where the substituents are as described in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.